Table 1 Baseline characteristics
Parameters | Normal LA (LAVi ≤ 34 ml/m2) | LA Enlargement (LAVi > 34 ml/m2) |
|---|---|---|
N = 306 | N = 257 | |
Age (years) | 68 (10) | 71 (9)** |
Male sex | 245 (61) | 154 (39)** |
BMI (kg/m2) | 26.9 (4) | 26.7 (4) |
BSA (m2) | 1.9 (0.2) | 1.8 (0.2)** |
CV risk Factors | ||
Familiar history (CVD) | 159 (56) | 120 (44) |
AHT | 159 (52) | 146 (48) |
DM | 83 (55) | 66 (45) |
Dyslipidaemia | 165 (57) | 120 (43) |
Types of cardiac surgery | ||
CABG | 197 (75) | 95 (25)** |
Heart-valve surgery | 73 (25) | 118 (75)** |
CABG + Valve surgery | 37 (46) | 43 (54) |
Clinical indications | ||
ACS | 116 (63) | 68 (37)* |
Stable Angina | 66 (67) | 32 (33)* |
MV Stenosis | 2 (22) | 7 (78) |
MV regurgitation | 44 (44) | 56 (56)* |
AV Stenosis | 23 (32) | 20 (68)** |
AV regurgitation | 19 (46) | 22 (54) |
Other indication | 36 (62) | 22 (38) |
Echocardiographic parameters | ||
LAV (ml) | 49 (11) | 85 (22)** |
LAd (mm) | 38 (5) | 54 (6)** |
LVEF (%) | 52 (9) | 49 (10)* |
LV EDV (ml) | 105 (41) | 108 (42) |
IVS (mm) | 12 (2) | 13 (2)** |
E/A Ratio | 1 (0.4) | 1 (0.6) |
Medications | ||
β-Blocker | 201 (52) | 185 (48) |
Amiodarone | 79 (51) | 77 (49) |
OAT | 72 (38) | 117 (62)** |
ACEi | 216 (57) | 170 (43)** |
Statins | 218 (56) | 168 (44)** |